Literature DB >> 20130923

Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury.

Krisztina Rusai1, Daniel Sollinger, Marcus Baumann, Bettina Wagner, Matthias Strobl, Christoph Schmaderer, Marcel Roos, Carsten Kirschning, Uwe Heemann, Jens Lutz.   

Abstract

Toll-like receptors (TLRs) are an evolutionarily conserved family of cell membrane receptors that are part of the innate immunity system playing an important role as a first response to tissue injury. TLR2 and TLR4 are constitutively expressed on renal epithelium, and their expression is enhanced following renal ischemia/reperfusion (I/R) injury. Genetic deletion of either TLR2 or TLR4 protects from renal I/R injury. However, it is not known whether deletion of both combined protects the kidney more than a deletion of either one alone. Therefore, we performed renal I/R injury in mice lacking TLR2, TLR4, and TLR2/4, respectively. Our results demonstrate that there are no significant differences regarding protection from renal I/R injury in TLR2/4((-/-)) compared with either TLR2((-/-)) or TLR4((-/-)) gene-targeted mice as determined by histological evaluation and renal functional parameters. Furthermore, there was no difference in the number of apoptotic tubular cells and in nuclear translocation of nuclear factor kappa-B (NF-kappaB) between the TLR-gene-targeted groups. In parallel, in vitro experiments did not demonstrate an additional effect of the double genetic deletion compared with the single gene deletion with respect to tumor necrosis factor (TNF)-alpha and interleukin (IL)-8 production in hypoxic isolated proximal tubular epithelial cells of the respective animals. In conclusion, a double genetic deletion of TLR2 and TLR4 confers a similar protection following renal I/R injury compared with single deletions of TLR2 and TLR4.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20130923     DOI: 10.1007/s00467-009-1422-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  13 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 2.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

Review 3.  Recognition and signaling by toll-like receptors.

Authors:  A Phillip West; Anna Alicia Koblansky; Sankar Ghosh
Journal:  Annu Rev Cell Dev Biol       Date:  2006       Impact factor: 13.827

4.  In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-gamma and TNF-alpha mediated up-regulation during inflammation.

Authors:  Tim G A M Wolfs; Wim A Buurman; Annemarie van Schadewijk; Bart de Vries; Marc A R C Daemen; Pieter S Hiemstra; Cornelis van 't Veer
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

5.  Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.

Authors:  Masahiro Yamamoto; Shintaro Sato; Kiyotoshi Mori; Katsuaki Hoshino; Osamu Takeuchi; Kiyoshi Takeda; Shizuo Akira
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

6.  Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.

Authors:  Yuan Zhai; Xiu-da Shen; Ryan O'Connell; Feng Gao; Charles Lassman; Ronald W Busuttil; Genhong Cheng; Jerzy W Kupiec-Weglinski
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

7.  Ischemia-reperfusion injury activates innate immunity in rat kidneys.

Authors:  Byung Soo Kim; Sun Woo Lim; Can Li; Jung Shim Kim; Bo Kyung Sun; Kyung Ohk Ahn; Sang Woo Han; Jin Kim; Chul Woo Yang
Journal:  Transplantation       Date:  2005-05-27       Impact factor: 4.939

8.  TLR4 activation mediates kidney ischemia/reperfusion injury.

Authors:  Huiling Wu; Gang Chen; Kate R Wyburn; Jianlin Yin; Patrick Bertolino; Josette M Eris; Stephen I Alexander; Alexandra F Sharland; Steven J Chadban
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

Review 9.  Pathophysiology of acute kidney injury: roles of potential inhibitors of inflammation.

Authors:  Joseph V Bonventre
Journal:  Contrib Nephrol       Date:  2007       Impact factor: 1.580

Review 10.  Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart.

Authors:  Wei Chao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-11-14       Impact factor: 4.733

View more
  34 in total

1.  Early interleukin 6 production by leukocytes during ischemic acute kidney injury is regulated by TLR4.

Authors:  Jianlin Chen; John R Hartono; Reji John; Michael Bennett; Xin Jin Zhou; Yanxia Wang; Qingqing Wu; Pamela D Winterberg; Glenn T Nagami; Christopher Y Lu
Journal:  Kidney Int       Date:  2011-06-01       Impact factor: 10.612

Review 2.  Role of T cell-nuclear factor κB in transplantation.

Authors:  Luciana L Molinero; Maria-Luisa Alegre
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

Review 3.  How the Innate Immune System Senses Trouble and Causes Trouble.

Authors:  Takashi Hato; Pierre C Dagher
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-20       Impact factor: 8.237

Review 4.  Sisters in arms: myeloid and tubular epithelial cells shape renal innate immunity.

Authors:  Takashi Hato; Tarek M El-Achkar; Pierre C Dagher
Journal:  Am J Physiol Renal Physiol       Date:  2013-03-20

5.  The effects of preoperative immunosuppressive therapy on ischemia and reperfusion (I/R) injury in healthy rats.

Authors:  Selcuk Kilinc; Sedat Tan; Efsun Hatice Kolatan; Dane Ruscuklu; Esra Satici; Mehmet Kemiksiz; Lutfi Dalkilic; Umut Eren Erdogdu; Cezmi Karaca
Journal:  Int Urol Nephrol       Date:  2013-09-08       Impact factor: 2.370

6.  Blocking innate immunity to slow the progression of chronic kidney disease.

Authors:  Christoph Schmaderer; Uwe Heemann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-10       Impact factor: 3.000

Review 7.  Acute kidney injury: a conspiracy of Toll-like receptor 4 on endothelia, leukocytes, and tubules.

Authors:  Christopher Y Lu; Pamela D Winterberg; Jianlin Chen; John R Hartono
Journal:  Pediatr Nephrol       Date:  2011-10-28       Impact factor: 3.714

Review 8.  Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury.

Authors:  Hailin Zhao; Jessica Santiváñez Perez; Kaizhi Lu; Andrew J T George; Daqing Ma
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-12

9.  Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation.

Authors:  Jens Lutz; Klaus Thürmel; Uwe Heemann
Journal:  J Inflamm (Lond)       Date:  2010-05-28       Impact factor: 4.981

Review 10.  TLR2 and TLR4 in ischemia reperfusion injury.

Authors:  F Arslan; B Keogh; P McGuirk; A E Parker
Journal:  Mediators Inflamm       Date:  2010-06-09       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.